Literature DB >> 26989261

Designing dose finding studies with an active control for exponential families.

Holger Dette1, Katrin Kettelhake1, Frank Bretz2.   

Abstract

In a recent paper Dette et al. (2014) introduced optimal design problems for dose finding studies with an active control. These authors concentrated on regression models with normal distributed errors (with known variance) and the problem of determining optimal designs for estimating the smallest dose, which achieves the same treatment effect as the active control. This paper discusses the problem of designing active-controlled dose finding studies from a broader perspective. In particular, we consider a general class of optimality criteria and models arising from an exponential family, which are frequently used analyzing count data. We investigate under which circumstances optimal designs for dose finding studies including a placebo can be used to obtain optimal designs for studies with an active control. Optimal designs are constructed for several situations and the differences arising from different distributional assumptions are investigated in detail. In particular, our results are applicable for constructing optimal experimental designs to analyze active-controlled dose finding studies with discrete data, and we illustrate the efficiency of the new optimal designs with two recent examples from our consulting projects.

Entities:  

Keywords:  active control; dose estimation; dose response; optimal designs

Year:  2015        PMID: 26989261      PMCID: PMC4790467          DOI: 10.1093/biomet/asv041

Source DB:  PubMed          Journal:  Biometrika        ISSN: 0006-3444            Impact factor:   2.445


  4 in total

1.  Adaptive designs for dose-finding studies based on sigmoid Emax model.

Authors:  Vladimir Dragalin; Francis Hsuan; S Krishna Padmanabhan
Journal:  J Biopharm Stat       Date:  2007       Impact factor: 1.051

2.  Optimal designs for estimating the interesting part of a dose-effect curve.

Authors:  Frank Miller; Olivier Guilbaud; Holger Dette
Journal:  J Biopharm Stat       Date:  2007       Impact factor: 1.051

Review 3.  Dose finding - a challenge in statistics.

Authors:  Frank Bretz; Jason Hsu; José Pinheiro; Yi Liu
Journal:  Biom J       Date:  2008-08       Impact factor: 2.207

4.  Point and Interval Estimators of the Target Dose in Clinical Dose-Finding Studies with Active Control.

Authors:  H-J Helms; N Benda; T Friede
Journal:  J Biopharm Stat       Date:  2014-06-11       Impact factor: 1.051

  4 in total
  1 in total

1.  Optimal designs for active controlled dose-finding trials with efficacy-toxicity outcomes.

Authors:  K Schorning; H Dette; K Kettelhake; W K Wong; F Bretz
Journal:  Biometrika       Date:  2017-10-09       Impact factor: 2.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.